Description

In this candid fireside chat, Bryan Gilpin, President of Suntra MedTech Solutions, joins Paul LaViolette, Co-Chairman and CEO of Pulse Biosciences (NASDAQ: PLSE), Managing Partner at SV Health Investors, and former COO of Boston Scientific, to explore the state of medtech innovation—where we're headed, and how investors, strategics, entrepreneurs, and service providers must collaborate to build the future together.

Framed as a point–counterpoint discussion, the conversation will reveal real-world lessons and actionable insights drawn from consulting, investing, and managerial perspectives—spanning decades of experience at the epicenters of medtech innovation.

With medtech revenues in North America and Europe projected to surpass $650 billion by 2028, the race to innovate has never been more intense. Product cycles are compressing, innovation windows are narrowing, and the tolerance for error—in patient safety and market perception—is shrinking fast. Amid current global economic and political upheaval, the widening gap between medtech winners and losers continues to accelerate. Artificial intelligence (AI) presents both a threat and an opportunity across the healthcare ecosystem.

Attendees will gain an insider’s view into the future of medtech innovation—and the implications for all of us. We each have an important role to play.

REGISTER HERE